The European Commission (EC) has granted approval for Takeda's antibody-drug conjugate (ADC) Adcetris (brentuximab vedotin).

Kite Pharma’s bicistronic CAR T-cell therapy hit the main goal of a phase 1a trial, with zero dose-limiting toxicities (DLTs) ...

Boston Red Sox relief pitcher Liam Hendriks has been placed on the 15-day injured list with inflammation in his right hip. The Red Sox announced the move is retroactive to Wednesday and ...

Lymphomas are cancers that start in white blood cells called lymphocytes. There are 2 main types of lymphoma: Hodgkin lymphoma (HL) Non-Hodgkin lymphoma (NHL) HL and NHL come from different types of ...

Explore Allogene's innovative CAR-T therapies targeting cancer & autoimmune diseases. ASCO updates on ALLO-316 could validate ...

The effects of obesity on cancer treatment efficacy remain unclear, as both beneficial and detrimental modulations of the tumor immune microenvironment have been reported. We compared 68Ga-NOTA-GZP ...

The model combines the biologically plausibility of Hodgkin-Huxley-type dynamics and the computational efficiency of integrate-and-fire neurons. Using this model, one can simulate tens of thousands of ...

The least absolute shrinkage and selection operator-logistic regression (Lasso-LR) model is optimal for predicting ...

Efforts to improve outcomes of patients with early-stage Hodgkin lymphoma (HL) and minimize the risk of short- and long-term toxicities have been made. In particular, different positron emission ...

Study design of the German Society of Pediatric Oncology and Hematology Hodgkin Lymphoma Trial 95 ... in univariate and multivariate analyses using the Cox regression model. 13 The cutoff for data ...

LSU former gymnast Olivia Dunne watches the game between the New York Mets and the Pittsburgh Pirates during the second inning at Citi Field. / Brad Penner-Imagn Images Livvy Dunne has been ...

A handful of people make up the core of your care team. You will have a hematologist-oncologist and a registered nurse who are experienced in caring for people with Hodgkin lymphoma. At some visits, ...